Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study

[1]  J. Di Domizio,et al.  Netting Neutrophils Activate Autoreactive B Cells in Lupus , 2018, The Journal of Immunology.

[2]  D. Witte,et al.  Urine S100 proteins as potential biomarkers of lupus nephritis activity , 2017, Arthritis Research & Therapy.

[3]  Betty Y. S. Kim,et al.  S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma. , 2017, Cancer research.

[4]  Shiwu Zhang,et al.  S100A4 in cancer progression and metastasis: A systematic review , 2017, Oncotarget.

[5]  A. Bengtsson,et al.  Platelet‐Derived S100A8/A9 and Cardiovascular Disease in Systemic Lupus Erythematosus , 2016, Arthritis & rheumatology.

[6]  Liuxing Wang,et al.  S100A4 participates in epithelial-mesenchymal transition in breast cancer via targeting MMP2 , 2016, Tumor Biology.

[7]  R. Jonsson,et al.  Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab , 2016, Scandinavian journal of rheumatology.

[8]  T. Pisitkun,et al.  Elevated expressions of myeloid-related proteins-8 and -14 are danger biomarkers for lupus nephritis , 2016, Lupus.

[9]  David J Weber,et al.  S100 proteins in cancer , 2015, Nature Reviews Cancer.

[10]  L. Pleštilová,et al.  High levels of metastasis-inducing S100A4 protein and treatment outcome in early rheumatoid arthritis: data from the PERAC cohort , 2015, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[11]  L. Pleštilová,et al.  The metastasis promoting protein S100A4 levels associate with disease activity rather than cancer development in patients with idiopathic inflammatory myopathies , 2014, Arthritis Research & Therapy.

[12]  M. Remáková,et al.  The metastasis-associated protein S100A4 promotes the inflammatory response of mononuclear cells via the TLR4 signalling pathway in rheumatoid arthritis. , 2014, Rheumatology.

[13]  M. Grigorian,et al.  S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis , 2014, Annals of the rheumatic diseases.

[14]  Zhihua Liu,et al.  S100 protein family in human cancer. , 2014, American journal of cancer research.

[15]  B. Zhivotovsky,et al.  S100A4 interacts with p53 in the nucleus and promotes p53 degradation , 2013, Oncogene.

[16]  O. Nived,et al.  Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus. , 2013, Rheumatology.

[17]  R. Donato,et al.  Functions of S100 proteins. , 2012, Current molecular medicine.

[18]  B. Jallal,et al.  Biomarkers for systemic lupus erythematosus , 2012, International journal of rheumatic diseases.

[19]  J. Ahearn,et al.  Biomarkers for systemic lupus erythematosus. , 2012, Translational research : the journal of laboratory and clinical medicine.

[20]  G. Schett,et al.  Immune complex formation after exposure of autoantigens on the surface of secondary necrotic cells (SNEC) promotes inflammation in SLE , 2012 .

[21]  M. Ward,et al.  Validation of new biomarkers in systemic autoimmune diseases , 2011, Nature Reviews Rheumatology.

[22]  P. Strzyz,et al.  S100A4 deficiency is associated with efficient bacterial clearance and protects against joint destruction during Staphylococcal infection. , 2011, The Journal of infectious diseases.

[23]  L. Pleštilová,et al.  Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis , 2011, Arthritis research & therapy.

[24]  Matthias Kretzler,et al.  Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus , 2011, The Journal of Immunology.

[25]  L. Truedsson,et al.  Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus , 2011, Arthritis research & therapy.

[26]  Tomoki Ito,et al.  Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA–Peptide Complexes in Systemic Lupus Erythematosus , 2011, Science Translational Medicine.

[27]  J. Connolly,et al.  Netting Neutrophils Are Major Inducers of Type I IFN Production in Pediatric Systemic Lupus Erythematosus , 2011, Science Translational Medicine.

[28]  Janice Branson,et al.  Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056 , 2011, Science Translational Medicine.

[29]  B. Reizis,et al.  Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells. , 2010, Immunity.

[30]  Y. Yeung,et al.  Optimal timing of elective laparoscopic cholecystectomy after acute cholangitis and subsequent clearance of choledocholithiasis. , 2010, American journal of surgery.

[31]  Abdul Hakkim,et al.  Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis , 2010, Proceedings of the National Academy of Sciences.

[32]  W. Chazin,et al.  S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3 , 2010, Cell Research.

[33]  W. Nacken,et al.  Neutrophil Extracellular Traps Contain Calprotectin, a Cytosolic Protein Complex Involved in Host Defense against Candida albicans , 2009, PLoS pathogens.

[34]  T. Vogl,et al.  Phagocyte-specific S100A8/A9 Protein Levels During Disease Exacerbations and Infections in Systemic Lupus Erythematosus , 2009, The Journal of Rheumatology.

[35]  J. L. Hansen,et al.  S100A4: a common mediator of epithelial–mesenchymal transition, fibrosis and regeneration in diseases? , 2008, Journal of molecular medicine.

[36]  K. Pavelka,et al.  Up-regulation of metastasis-promoting S100A4 (Mts-1) in rheumatoid arthritis: putative involvement in the pathogenesis of rheumatoid arthritis. , 2007, Arthritis and rheumatism.

[37]  D. Foell,et al.  S100 proteins expressed in phagocytes: a novel group of damage‐associated molecular pattern molecules , 2007, Journal of leukocyte biology.

[38]  M. Bianchi.  DAMPs, PAMPs and alarmins: all we need to know about danger , 2007, Journal of leukocyte biology.

[39]  A. Bresnick,et al.  The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA. , 2006, Cancer research.

[40]  M. Salto‐Tellez,et al.  Metastasis‐associated protein S100A4—a potential prognostic marker for colorectal cancer , 2006, Journal of surgical oncology.

[41]  Simon B. Brown,et al.  Impaired recognition of apoptotic neutrophils by the C1q/calreticulin and CD91 pathway in systemic lupus erythematosus. , 2006, Arthritis and rheumatism.

[42]  A. Cappione,et al.  Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. , 2005, The Journal of clinical investigation.

[43]  J. Smolen,et al.  The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. , 2005, Clinical and experimental rheumatology.

[44]  D. Foell,et al.  Proinflammatory S100 proteins in arthritis and autoimmune disease. , 2004, Arthritis and rheumatism.

[45]  E. Mossad,et al.  Cerebral function monitors during pediatric cardiac surgery: can they make a difference? , 2004, Journal of cardiothoracic and vascular anesthesia.

[46]  A. Zychlinsky,et al.  Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.

[47]  C. Lau,et al.  Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. , 2003, Arthritis and rheumatism.

[48]  D. Neal,et al.  Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer , 2002, The Journal of pathology.

[49]  D. Gladman,et al.  Systemic lupus erythematosus disease activity index 2000. , 2002, The Journal of rheumatology.

[50]  G. Selivanova,et al.  Tumor Suppressor p53 Protein Is a New Target for the Metastasis-associated Mts1/S100A4 Protein , 2001, The Journal of Biological Chemistry.

[51]  R du Berger,et al.  The relationship between disease activity and expert physician's decision to start major treatment in active systemic lupus erythematosus: a decision aid for development of entry criteria for clinical trials. , 1998, The Journal of rheumatology.

[52]  R. Kalluri,et al.  Early role of Fsp1 in epithelial-mesenchymal transformation. , 1997, American journal of physiology. Renal physiology.

[53]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[54]  Y. Okada.  Volume expansion-sensing outward-rectifier Cl- channel: fresh start to the molecular identity and volume sensor. , 1997, The American journal of physiology.

[55]  B. Richardson,et al.  Monocyte apoptosis in patients with active lupus. , 1996, Arthritis and rheumatism.

[56]  M. Grigorian,et al.  The mts1 gene and control of tumor metastasis. , 1993, Gene.

[57]  G. Hughes,et al.  Calprotectin in Patients with Systemic Lupus Erythematosus: Relation to Clinical and Laboratory Parameters of Disease Activity , 1993, Lupus.

[58]  D. Isenberg,et al.  Systemic lupus erythematosus , 1956, The Lancet.

[59]  A. Marshak‐Rothstein,et al.  Toll-Like Receptor-Dependent Immune Complex Activation of B Cells and Dendritic Cells. , 2016, Methods in molecular biology.

[60]  J. Zibert,et al.  Significance of the S100A4 protein in psoriasis. , 2010, The Journal of investigative dermatology.

[61]  F. Sedaghat,et al.  S100 protein family and its application in clinical practice. , 2008, Hippokratia.

[62]  O. Rekvig,et al.  Cardiovascular, Pulmonary and Renal Pathology Nephritogenic Lupus Antibodies Recognize Glomerular Basement Membrane-Associated Chromatin Fragments Released from Apoptotic Intraglomerular Cells , 2006 .